-
Mashup Score: 0Medicine Advances - 7 month(s) ago
Submission deadline: Jan. 31, 2024 Since the advent of multi-omics technologies, encompassing single-cell and bulk-level transcriptomics, proteomics, and metabolomics, these approaches have broadly applied in and significantly advanced the fields of basic and clinical research. They have played a crucial role in shedding light on the occurrence and development mechanisms of diseases, both through the utilization of animal models and clinical samples. Furthermore, these methodologies have aided in the
Source: onlinelibrary.wiley.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2
Wednesday, 19Â April, 2023 FEATURED ABSTRACTS After an exciting conference welcome from program chairs Andreas Zuckermann, MD and Howard Eisen, MD, this featured abstract was introduced wherein Sebastien Hascoet, MD, PhD and colleagues from Marie Lannelongue Hospital in Paris, France presented a retrospective cohort study comparing 61 consecutive pediatric patients with severe pulmonary artery…
Source: www.ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Telomeres Encode Disease-Relevant Proteins - 1 year(s) ago
Researchers suggest that simple blood tests for telomere-encoded proteins could provide a valuable screen for certain cancers and other human diseases.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 9Telomeres Encode Disease-Relevant Proteins - 1 year(s) ago
Researchers suggest that simple blood tests for telomere-encoded proteins could provide a valuable screen for certain cancers and other human diseases.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Spatial Technology Offers Spectacular Insights - 1 year(s) ago
Besides providing dazzling visuals, spatial technology—the latest omics craze—is digging into rich data sets and uncovering meaningful results.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission - 1 year(s) ago
We have made substantial progress in developing cancer treatments that target specific molecular vulnerabilities in an increasing number of cancer types.1 Interrogation of complex genomic, transcriptomic, and metabolomic (referred to as omics) profiles, integrated with comprehensive clinical data, represents the essential next step to inform the development and application of selective approaches…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity - 1 year(s) ago
AbstractAims. Calcific aortic valve disease (CAVD) is the most common valve disease, which consists of a chronic interplay of inflammation, fibrosis, and calcif
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Gut Bacteria Influences Immune Cell Behavior - 1 year(s) ago
A new study in mice suggests reshaping the gut microbiome as a way to prevent or treat neurodegeneration.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Cell Press Selections 2022_Advances in live-cell imaging and omics in organoid models - 1 year(s) ago
Cell Press Selections 2022_Advances in live-cell imaging and omics in organoid models
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Epigenomic Links Between Social Determinants of Health and Symptoms: A Scoping Review - PubMed - 1 year(s) ago
Social determinants of health (SDoH) impact health and wellness. The link between SDoH and adverse health outcomes, including symptom occurrence and severity, may be explained by an individual’s physiologic response to one or more SDoH. One potential mechanism underlying this physiologic response li …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
Submit your work to Medicine Advances for a special issue, Application of #Omics in Diseases. Good news for authors: Article Publication Charges (APCs) are waived! 📅 Submit by January 31, 2024. Find out more now. 👉 https://t.co/ax6JAL69Kk #OpenAccess https://t.co/w0qozBFPIC